Statements (21)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:biotechnology
|
| gptkbp:country |
gptkb:United_States
|
| gptkbp:foundedIn |
1999
|
| gptkbp:founder |
gptkb:Stephen_Quake
gptkb:Gajus_Worthington |
| gptkbp:headquartersLocation |
gptkb:South_San_Francisco,_California,_United_States
|
| https://www.w3.org/2000/01/rdf-schema#label |
Fluidigm
|
| gptkbp:industry |
gptkb:biotechnology
|
| gptkbp:keyPerson |
gptkb:Chris_Linthwaite
gptkb:Gajus_Worthington |
| gptkbp:numberOfEmployees |
~600 (as of 2021)
|
| gptkbp:product |
single-cell genomics
mass cytometry microfluidic systems |
| gptkbp:renamed |
gptkb:Standard_BioTools
2022 |
| gptkbp:stockExchange |
gptkb:NASDAQ
|
| gptkbp:tradedOn |
gptkb:NASDAQ:FLDM
|
| gptkbp:website |
https://www.fluidigm.com/
|
| gptkbp:bfsParent |
gptkb:Standard_BioTools
|
| gptkbp:bfsLayer |
6
|